enkephalin, ser(2), leu(5), thr(6)- has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
| Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) | Trials (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) | Recent Studies (post-2010) (4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide) |
|---|---|---|---|---|---|
| 224 | 0 | 5 | 279 | 0 | 85 |
| Protein | Taxonomy | enkephalin, ser(2), leu(5), thr(6)- (IC50) | 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0842 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0879 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 4.7722 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 3.601 | |
| Mu-type opioid receptor | Homo sapiens (human) | 1.8083 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0086 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.85 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 2.48 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 6.066 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, D; Coop, A; MacKerell, AD | 1 |
1 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
| Article | Year |
|---|---|
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.
Topics: Animals; Cell Line, Tumor; Enkephalin, Leucine; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Phenylalanine; Quantitative Structure-Activity Relationship; Rats; Receptors, Opioid, delta | 2007 |